Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Epidemiology

Evidence that the Spread of Mycobacterium tuberculosis Strains with the Beijing Genotype Is Human Population Dependent

M. Hanekom, G. D. van der Spuy, N. C. Gey van Pittius, C. R. E. McEvoy, S. L. Ndabambi, T. C. Victor, E. G. Hoal, P. D. van Helden, R. M. Warren
M. Hanekom
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. D. van der Spuy
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. C. Gey van Pittius
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. R. E. McEvoy
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. L. Ndabambi
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. C. Victor
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. G. Hoal
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. D. van Helden
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. M. Warren
DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rw1@sun.ac.za
DOI: 10.1128/JCM.02354-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • Evidence that the Spread of Mycobacterium tuberculosis Strains with the Beijing Genotype Is Human Population Dependent
    - June 30, 2011

ABSTRACT

This study describes a comparative analysis of the Beijing mycobacterial interspersed repetitive unit types of Mycobacterium tuberculosis isolates from Cape Town, South Africa, and East Asia. The results show a significant association between the frequency of occurrence of strains from defined Beijing sublineages and the human population from whom they were cultured (P < 0.0001).

Mycobacterium tuberculosis strains with the Beijing genotype have been shown to be globally widespread and are particularly prevalent in East Asia, where over 80% of strains from the Beijing, China, region are of this genotype (5). It has been hypothesized that Beijing strains have evolved unique properties, including the ability to evade the protective effect of Mycobacterium bovis BCG vaccination (19) and the ability to spread more efficiently than non-Beijing strains (2). However, the clinical presentations of patients with tuberculosis caused by a Beijing strain were found to vary between different geographical settings (3-5, 16). Currently, it is not known whether the observed variability in clinical presentation is a function of the Beijing strain population found in particular geographical settings, is a function of the genetic composition of the human population, or is a function of a combination of these two variables.

This study aimed to test the hypothesis that host-pathogen compatibility determined the Beijing strain population structure in different host populations in different geographical settings. Cultures of M. tuberculosis isolates from patients of mixed ancestry (14) who were resident in Cape Town, South Africa (20), were classified as being of the Beijing genotype by spoligotyping (10). The Beijing strains were assigned to phylogenetic sublineages as described previously (8) and were genotyped by mycobacterial interspersed repetitive unit (MIRU) typing (17).

During the study period (January 1993 to December 2004), 25 MIRU types were identified among 321 tuberculosis cases infected with a Beijing strain (Table 1). A comparison of the MIRU type data for the Beijing strains from Cape Town and previously published MIRU type data for the Beijing strains from East Asia (1, 9, 12, 13, 15, 18) showed that nine of the Beijing MIRU types (types MT01, MT08, MT11, MT18, MT19, MT21, MT28, MT33, and MT54) were shared between these geographical settings (Table 1). This suggests that the nine shared Beijing MIRU types represent founder strains that were introduced into Cape Town from East Asia, as the latter is thought to be the evolutionary origin of strains with a Beijing genotype (5, 7, 12). The definition of founder MIRU types was supported by their disproportionately high number (n = 267) compared to the number with nonfounder MIRU types (n = 54) in tuberculosis patients from Cape Town (z test for the hypothesis that the proportion of types were founder MIRU types = 0.5; P < 0.001).

Superimposition of the Beijing MIRU type data onto the previously described phylogenetic tree of the Beijing strain family (8) provided a framework that could be used to predict the evolutionary order in which the 25 Beijing MIRU types had evolved (Fig. 1). From this prediction, the Beijing MIRU types could be partitioned into seven Beijing sublineages. The number of founder Beijing MIRU types was variable among the different Beijing sublineages (Fig. 1). Twenty-four of the Beijing MIRU types were unique to their respective sublineages, while the remaining Beijing MIRU type (MT11) was shared by three different sublineages (sublineages 2, 3, and 6) (Fig. 1 and Table 1), suggesting that MT11 was an ancestral Beijing MIRU type (12).

To determine the propensity of Beijing strains from the different sublineages to spread in the human population in Cape Town, the number of cases in circulation within each sublineage was compared to the number of founder strains for that sublineage (Table 1). The number of representatives of these founder strains was shown to be overrepresented in sublineage 7 (n = 233 cases from one founder strain) compared with the numbers in sublineages 1 to 6 (n = 88 cases from eight founder strains) (z test for the hypothesis that the proportion of sublineage 7 cases = 0.11; P < 0.001). In comparison, founder Beijing MIRU types MT01, MT08, MT11, MT18, MT19, MT21, MT33, and MT54 were overrepresented in the human population in East Asia (China, 73/130; Hong Kong, 108/211; Vietnam, 25/37; and Singapore, 45/56) compared to their representation in Cape Town, South Africa (79/321) (Fisher's exact test odds ratio [OR], 4.20; 95% confidence interval [CI], 3.06 to 5.77; P < 0.0001).

A significant association between the frequency of occurrence of strains of defined Beijing sublineages and the human population from whom they were isolated was observed (for sublineages 1 to 6, n = 88 for Cape Town and n = 253 for East Asia; for sublineage 7, n = 233 for Cape Town and n = 43 for East Asia; Fisher's exact test OR, 15.58; 95% CI, 10.38 to 23.38; P < 0.0001).

It is unlikely that these findings can be explained by multiple importations of founder strains of sublineage 7 in preference to founder strains of sublineages 1 to 6, given that immigrants to South Africa came from many different geographical regions in East Asia and that sublineage 7 founder strains are less frequently observed in East Asia. Accordingly, we propose that the situation in Cape Town represents an approximation to a common starting point for all the founder strains introduced, with those best adapted to the local population spreading most efficiently. This could be due to the innate characteristics of the strains within defined Beijing sublineages or the local host population. Susceptibility to M. tuberculosis per se has frequently been associated with the HLA genotype (11), and HLA allele frequencies are known to differ widely between human populations with different histories, with certain alleles totally absent in some populations. Our conclusion differs from that of Gagneux et al. (6), as we demonstrate that strains from a defined sublineage (a subset of strains from an evolutionary lineage) may have been selected by a human population in a defined geographical setting.

In summary, the global success of the Beijing lineage may reflect either the selection of defined sublineages in different geographical settings by distinct human populations or the adaptation of strains in a defined sublineage to spread more readily in a distinct human population. We acknowledge that these contrasting conclusions cannot be easily distinguished with the available data. However, the emergence of a sublineage of Beijing strains with increased pathogenicity may have important implications for the Tuberculosis Control Program. Early diagnosis and contact tracing will be essential to curb the spread of these strains. Furthermore, it will be important to ensure that future vaccines protect against these strains.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Evolutionary scenario of Beijing MIRU types according to Beijing sublineage. Beijing MIRU types were grouped according to their respective Beijing sublineages (8), and the most parsimonious evolutionary order was proposed. The Beijing MIRU types are indicated within each box. Founder Beijing MIRU types are indicated by bold boxes. Unknown Beijing MIRU types are indicated by “?.”

View this table:
  • View inline
  • View popup
TABLE 1.

Geographical distribution of Beijing MIRU types from Asia and South Africa

ACKNOWLEDGMENTS

We thank the TB in the 21st Century Consortium, the Harry Crossley Foundation, and the European Commission 6th Framework Program on Research Technological Development Demonstration (project no. 037919) for financially supporting this project.

We thank M. Kidd for statistical advice.

FOOTNOTES

    • Received 21 November 2006.
    • Returned for modification 30 March 2007.
    • Accepted 23 April 2007.
  • Copyright © 2007 American Society for Microbiology

REFERENCES

  1. 1.↵
    Banu, S., S. V. Gordon, S. Palmer, M. R. Islam, S. Ahmed, K. M. Alam, S. T. Cole, and R. Brosch. 2004. Genotypic analysis of Mycobacterium tuberculosis in Bangladesh and prevalence of the Beijing strain. J. Clin. Microbiol.42:674-682.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    Bifani, P. J., B. Mathema, N. E. Kurepina, and B. N. Kreiswirth. 2002. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol.10:45-52.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Borgdorff, M. W., H. van Deutekom, P. E. de Haas, K. Kremer, and D. van Soolingen. 2004. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinburgh)84:337-340.
    OpenUrlCrossRef
  4. 4.
    Drobniewski, F., Y. Balabanova, V. Nikolayevsky, M. Ruddy, S. Kuznetzov, S. Zakharova, A. Melentyev, and I. Fedorin. 2005. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA293:2726-2731.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. 2006. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg. Infect. Dis.12:736-743.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Gagneux, S., K. DeRiemer, T. Van, M. Kato-Maeda, B. C. de Jong, S. Narayanan, M. Nicol, S. Niemann, K. Kremer, M. C. Gutierrez, M. Hilty, P. C. Hopewell, and P. M. Small. 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA103:2869-2873.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Glynn, J. R., J. Whiteley, P. J. Bifani, K. Kremer, and D. van Soolingen. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis.8:843-849.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Hanekom, M., G. D. van der Spuy, E. Streicher, S. L. Ndabambi, C. R. McEvoy, M. Kidd, N. Beyers, T. C. Victor, P. D. van Helden, and R. M. Warren. 2007. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J. Clin. Microbiol.45:1483-1490.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Kam, K. M., C. W. Yip, L. W. Tse, K. L. Wong, T. K. Lam, K. Kremer, B. K. Au, and D. van Soolingen. 2005. Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family. J. Clin. Microbiol.43:306-313.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Kamerbeek, J., L. Schouls, A. Kolk, M. van Agterveld, D. van Soolingen, S. Kuijper, A. Bunschoten, H. Molhuizen, R. Shaw, M. Goyal, and J. Van Embden. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol.35:907-914.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Lombard, Z., A. E. Brune, E. G. Hoal, C. Babb, P. D. van Helden, J. T. Epplen, and L. Bornman. 2006. HLA class II disease associations in southern Africa. Tissue Antigens67:97-110.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    Mokrousov, I., H. M. Ly, T. Otten, N. N. Lan, B. Vyshnevskyi, S. Hoffner, and O. Narvskaya. 2005. Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. Genome Res.15:1357-1364.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    Mokrousov, I., O. Narvskaya, E. Limeschenko, A. Vyazovaya, T. Otten, and B. Vyshnevskiy. 2004. Analysis of the allelic diversity of the mycobacterial interspersed repetitive units in Mycobacterium tuberculosis strains of the Beijing family: practical implications and evolutionary considerations. J. Clin. Microbiol.42:2438-2444.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Nurse, G. T., J. S. Weiner, and T. Jenkins. 1985. The peoples of southern Africa and their affinities, p. 410. Clarendon Press, Oxford, United Kingdom.
  15. 15.↵
    Sun, Y. J., R. Bellamy, A. S. Lee, S. T. Ng, S. Ravindran, S. Y. Wong, C. Locht, P. Supply, and N. I. Paton. 2004. Use of mycobacterial interspersed repetitive unit-variable-number tandem repeat typing to examine genetic diversity of Mycobacterium tuberculosis in Singapore. J. Clin. Microbiol.42:1986-1993.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Sun, Y. J., T. K. Lim, A. K. Ong, B. C. Ho, G. T. Seah, and N. I. Paton. 2006. Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison. BMC Infect. Dis.6:105.
    OpenUrlCrossRefPubMed
  17. 17.↵
    Supply, P., S. Lesjean, E. Savine, K. Kremer, D. van Soolingen, and C. Locht. 2001. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J. Clin. Microbiol.39:3563-3571.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Supply, P., R. M. Warren, A. L. Banuls, S. Lesjean, G. D. van der Spuy, L. A. Lewis, M. Tibayrenc, P. D. van Helden, and C. Locht. 2003. Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area. Mol. Microbiol.47:529-538.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    van Soolingen, D., L. Qian, P. E. de Haas, J. T. Douglas, H. Traore, F. Portaels, H. Z. Qing, D. Enkhsaikan, P. Nymadawa, and J. D. van Embden. 1995. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J. Clin. Microbiol.33:3234-3238.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Verver, S., R. M. Warren, Z. Munch, E. Vynnycky, P. D. van Helden, M. Richardson, G. D. van der Spuy, D. A. Enarson, M. W. Borgdorff, M. A. Behr, and N. Beyers. 2004. Transmission of tuberculosis in a high incidence urban community in South Africa. Int. J. Epidemiol.33:351-357.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Evidence that the Spread of Mycobacterium tuberculosis Strains with the Beijing Genotype Is Human Population Dependent
M. Hanekom, G. D. van der Spuy, N. C. Gey van Pittius, C. R. E. McEvoy, S. L. Ndabambi, T. C. Victor, E. G. Hoal, P. D. van Helden, R. M. Warren
Journal of Clinical Microbiology Jul 2007, 45 (7) 2263-2266; DOI: 10.1128/JCM.02354-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evidence that the Spread of Mycobacterium tuberculosis Strains with the Beijing Genotype Is Human Population Dependent
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evidence that the Spread of Mycobacterium tuberculosis Strains with the Beijing Genotype Is Human Population Dependent
M. Hanekom, G. D. van der Spuy, N. C. Gey van Pittius, C. R. E. McEvoy, S. L. Ndabambi, T. C. Victor, E. G. Hoal, P. D. van Helden, R. M. Warren
Journal of Clinical Microbiology Jul 2007, 45 (7) 2263-2266; DOI: 10.1128/JCM.02354-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Mycobacterium tuberculosis
Tuberculosis, Pulmonary

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X